Newsletter Subject

Adding This New Criteria Drastically Cut 72-Hour Insulinoma Fast Time

From

medpagetoday.com

Email Address

daily.headlines@broadcaster3.medpagetoday.com

Sent On

Mon, May 8, 2023 10:52 PM

Email Preheader Text

Daily Headlines Monday, May 08, 2023 Today's Top Stories for {NAME} THE BREAK ROOM CME SPOTLIGHT THE

[MEDPAGE TODAY]( Daily Headlines Monday, May 08, 2023 Today's Top Stories for {NAME} [MEETING COVERAGE]( [Adding This New Criteria Drastically Cut 72-Hour Insulinoma Fast Time]( [PULMONOLOGY]( [Daytime Sleepiness Drugs of Varying Performance in Obstructive Sleep Apnea]( [CARDIOLOGY]( [GLP-1 Agonists Come Out on Top in Cardiovascular Comparison of Newer Diabetes Meds]( THE BREAK ROOM [Wordectomy: Guess Today’s Medical Condition]( CME SPOTLIGHT [Living with HR+/HER2- Breast Cancer: A Point-of-Care Oral Oncolytic Discussion Guide and Toolkit for Patients]( [PUBLIC HEALTH & POLICY]( [CMS Official Sees Rosy Future for ACOs]( [MEETING COVERAGE]( [GLP-1 RAs Safe Months After Kidney Transplant]( THE BREAK ROOM [Play Today’s Wordosis]( ADVERTISEMENT [PUBLIC HEALTH & POLICY]( [How Should the U.S. Prepare for the Next Pandemic?]( CME SPOTLIGHT [Advancing Post-Transplant CMV Care: Diagnosis and First-Line Treatment]( [OPINION]( [Perfect Is the Enemy of Good, and So Is Narcan Misinformation]( [NEUROLOGY]( [Neurologic Long COVID Patients Show Immune Dysregulation]( [CRITICAL CARE]( [Racial Disparities Linked to Length of Sepsis and Respiratory Failure Stays]( CME SPOTLIGHT [Advancing Post-Transplant CMV Care: Prophylactic and Preemptive Management]( [MEETING COVERAGE]( [Win for Vedolizumab in Recurrent Crohn's Disease]( [SPECIAL REPORTS]( [Cyberattacks a Problem for Nearby EDs, Too]( [PEDIATRICS]( [Maternal Opioid Use Disorder Raises Postneonatal Infant Mortality]( CME SPOTLIGHT [Current Evidence and Guidelines for Treatment Selection for Relapsed/Refractory Multiple Myeloma]( [OPINION]( [An Homage to Nurses, Everywhere]( [MEETING COVERAGE]( [Limited Effect of Laser Treatment on Eye Floaters]( [MEETING COVERAGE]( [Novel Hormone Replacer Holds Up Long-Term for Hypoparathyroidism]( CME SPOTLIGHT [Improving Patient-Centered Treatment and Management of PNH]( [MEETING COVERAGE]( [Study: VA Surgeons Who Do Colonoscopies May Need More Training]( [CASE STUDIES]( [Elderly Farmer Experiences Strange Abdominal Rash and GI Symptoms]( [AGA READING ROOM]( [David Assis on New Developments in Primary Sclerosing Cholangitis]( CME SPOTLIGHT [Navigating the Rapidly Evolving DLBCL Treatment Landscape to Deliver Quality Care]( [AGA READING ROOM]( [More Effective Management Strategies Are Needed for PSC]( [MEDICAL JOURNEYS]( [Case Study: Recurrence of Urothelial Cancer Challenging in Patient With Morbid Obesity]( [MEDICAL JOURNEYS]( [Case Study: Why Is This Young Boy's Atopic Dermatitis So Resistant to Treatment?]( [MEDICAL JOURNEYS]( [Melanoma: Survivorship Care]( [MEDICAL JOURNEYS]( [For Your Patients: Survivorship -- Living With Melanoma]( [MEETING COVERAGE]( [Lifestyle Factors and Glaucoma: Lots of Common Sense, Not So Much Evidence]( # Weekly Survey [Mask Up in Long COVID Trial?]( Participants in a long COVID trial at Stanford are upset with researchers for [not masking during clinic visits]([VOTE >]( Meeting Coverage Can't get away? MedPage Today brings you extensive coverage of more than 80 meetings in a wide range of specialties. [SEE ALL STORIES >]( Got a news tip? MedPage Today offers several ways to provide information to our journalists securely and confidentially. [LEARN MORE >]( [EVERYDAY HEALTH]( © 2023 MedPage Today, LLC. MedPage Today is among the federally registered trademarks of MedPage Today, LLC, and may not be used by third parties without explicit permission. You have received this email because you have registered to receive emails at www.medpagetoday.com, with the email address: {EMAIL} [Manage Email Preferences]( | [Unsubscribe](lst=NL_Daily_DHE?xid=nl_mpt_DHE_2023-05-08&eun=g1020308d0r) | [Terms of Use]( | [Privacy Policy]( Technical Questions: feedback@medpagetoday.com 114 5th Avenue, 15th Floor New York, NY 10011

Marketing emails from medpagetoday.com

View More
Sent On

08/12/2024

Sent On

08/11/2024

Sent On

07/11/2024

Sent On

07/11/2024

Sent On

06/11/2024

Sent On

04/11/2024

Email Content Statistics

Subscribe Now

Subject Line Length

Data shows that subject lines with 6 to 10 words generated 21 percent higher open rate.

Subscribe Now

Average in this category

Subscribe Now

Number of Words

The more words in the content, the more time the user will need to spend reading. Get straight to the point with catchy short phrases and interesting photos and graphics.

Subscribe Now

Average in this category

Subscribe Now

Number of Images

More images or large images might cause the email to load slower. Aim for a balance of words and images.

Subscribe Now

Average in this category

Subscribe Now

Time to Read

Longer reading time requires more attention and patience from users. Aim for short phrases and catchy keywords.

Subscribe Now

Average in this category

Subscribe Now

Predicted open rate

Subscribe Now

Spam Score

Spam score is determined by a large number of checks performed on the content of the email. For the best delivery results, it is advised to lower your spam score as much as possible.

Subscribe Now

Flesch reading score

Flesch reading score measures how complex a text is. The lower the score, the more difficult the text is to read. The Flesch readability score uses the average length of your sentences (measured by the number of words) and the average number of syllables per word in an equation to calculate the reading ease. Text with a very high Flesch reading ease score (about 100) is straightforward and easy to read, with short sentences and no words of more than two syllables. Usually, a reading ease score of 60-70 is considered acceptable/normal for web copy.

Subscribe Now

Technologies

What powers this email? Every email we receive is parsed to determine the sending ESP and any additional email technologies used.

Subscribe Now

Email Size (not include images)

Font Used

No. Font Name
Subscribe Now

Copyright © 2019–2025 SimilarMail.